United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...
UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...
His effort paid off: Tim Andrews, 66, is only the second person known to be living with a pig kidney. Andrews is free from ...
United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...
United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...
Kingswood Wealth Advisors LLC bought a new position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) during ...
Dr Catherine Headley highlights how the University of Manchester Innovation Factory transforms research into real-world impact, driving progress through spinouts, collaborations, ...
Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...
Corporation (NASDAQ: UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a pioneering clinical trial of its gene-edited xenotransplantation kidney, named UKidney, ...
Stoke City boss Mark Robins says an FA Cup semi-final defeat while in charge of Coventry City last season still feels "raw".
Manchester United academy midfielder Ruben Curley has sent an emotional message to his boyhood club after sealing a permanent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results